Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Admission to hospital
[105] RCT	5926 people with vascular disease who were intolerant to ACE inhibitors	Hospital admission for heart failure 134/2954 (4.5%) with telmisartan 129/2972 (4.3%) with placebo	HR 1.05 95% CI 0.82 to 1.34 P = 0.69		Not significant